WCN24-1063 The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in Diabetic Nephropathy and Non Diabetic Renal Disease in Diabetes Mellitus type2 Patients

Saved in:
Bibliographic Details
Main Authors: Maru Navarro, Montserrat Gomà, Ariel Tango, Oana Rap, Cristina Cabrera, Ana Sánchez, Neus Farré, Pilar Ruiz, Meritxell Ibernon
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924005473
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850127670069690368
author Maru Navarro
Montserrat Gomà
Ariel Tango
Oana Rap
Cristina Cabrera
Ana Sánchez
Neus Farré
Pilar Ruiz
Meritxell Ibernon
author_facet Maru Navarro
Montserrat Gomà
Ariel Tango
Oana Rap
Cristina Cabrera
Ana Sánchez
Neus Farré
Pilar Ruiz
Meritxell Ibernon
author_sort Maru Navarro
collection DOAJ
format Article
id doaj-art-3c67d2a53a58492e8670ff82561a84d2
institution OA Journals
issn 2468-0249
language English
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-3c67d2a53a58492e8670ff82561a84d22025-08-20T02:33:36ZengElsevierKidney International Reports2468-02492024-04-0194S22510.1016/j.ekir.2024.02.458WCN24-1063 The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in Diabetic Nephropathy and Non Diabetic Renal Disease in Diabetes Mellitus type2 PatientsMaru Navarro0Montserrat Gomà1Ariel Tango2Oana Rap3Cristina Cabrera4Ana Sánchez5Neus Farré6Pilar Ruiz7Meritxell Ibernon8Nephrology, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí. BarcelonaPathology, Hospital de Bellvitge, BarcelonaNephrology, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí. BarcelonaNephrology, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí. BarcelonaNephrology, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí. BarcelonaNephrology, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí. BarcelonaNephrology, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí. BarcelonaNephrology, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí. BarcelonaNephrology, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí. Barcelonahttp://www.sciencedirect.com/science/article/pii/S2468024924005473
spellingShingle Maru Navarro
Montserrat Gomà
Ariel Tango
Oana Rap
Cristina Cabrera
Ana Sánchez
Neus Farré
Pilar Ruiz
Meritxell Ibernon
WCN24-1063 The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in Diabetic Nephropathy and Non Diabetic Renal Disease in Diabetes Mellitus type2 Patients
Kidney International Reports
title WCN24-1063 The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in Diabetic Nephropathy and Non Diabetic Renal Disease in Diabetes Mellitus type2 Patients
title_full WCN24-1063 The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in Diabetic Nephropathy and Non Diabetic Renal Disease in Diabetes Mellitus type2 Patients
title_fullStr WCN24-1063 The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in Diabetic Nephropathy and Non Diabetic Renal Disease in Diabetes Mellitus type2 Patients
title_full_unstemmed WCN24-1063 The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in Diabetic Nephropathy and Non Diabetic Renal Disease in Diabetes Mellitus type2 Patients
title_short WCN24-1063 The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in Diabetic Nephropathy and Non Diabetic Renal Disease in Diabetes Mellitus type2 Patients
title_sort wcn24 1063 the role of sodium glucose cotransporter 2 sglt2 inhibitors in diabetic nephropathy and non diabetic renal disease in diabetes mellitus type2 patients
url http://www.sciencedirect.com/science/article/pii/S2468024924005473
work_keys_str_mv AT marunavarro wcn241063theroleofsodiumglucosecotransporter2sglt2inhibitorsindiabeticnephropathyandnondiabeticrenaldiseaseindiabetesmellitustype2patients
AT montserratgoma wcn241063theroleofsodiumglucosecotransporter2sglt2inhibitorsindiabeticnephropathyandnondiabeticrenaldiseaseindiabetesmellitustype2patients
AT arieltango wcn241063theroleofsodiumglucosecotransporter2sglt2inhibitorsindiabeticnephropathyandnondiabeticrenaldiseaseindiabetesmellitustype2patients
AT oanarap wcn241063theroleofsodiumglucosecotransporter2sglt2inhibitorsindiabeticnephropathyandnondiabeticrenaldiseaseindiabetesmellitustype2patients
AT cristinacabrera wcn241063theroleofsodiumglucosecotransporter2sglt2inhibitorsindiabeticnephropathyandnondiabeticrenaldiseaseindiabetesmellitustype2patients
AT anasanchez wcn241063theroleofsodiumglucosecotransporter2sglt2inhibitorsindiabeticnephropathyandnondiabeticrenaldiseaseindiabetesmellitustype2patients
AT neusfarre wcn241063theroleofsodiumglucosecotransporter2sglt2inhibitorsindiabeticnephropathyandnondiabeticrenaldiseaseindiabetesmellitustype2patients
AT pilarruiz wcn241063theroleofsodiumglucosecotransporter2sglt2inhibitorsindiabeticnephropathyandnondiabeticrenaldiseaseindiabetesmellitustype2patients
AT meritxellibernon wcn241063theroleofsodiumglucosecotransporter2sglt2inhibitorsindiabeticnephropathyandnondiabeticrenaldiseaseindiabetesmellitustype2patients